vimarsana.com

Latest Breaking News On - Neurobo pharmaceuticals inc - Page 10 : vimarsana.com

NEUROBO PHARMACEUTICALS APPOINTS HYUNG HEON KIM AS CHIEF EXECUTIVE OFFICER AND PRESIDENT

BOSTON, Aug. 14, 2023  /PRNewswire/ NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today announced the appointment of. -Today at 08:02 am- MarketScreener

NeuroBo Appoints Hyung Heon Kim As CEO

(RTTNews) - NeuroBo Pharmaceuticals, Inc. (NRBO), a company focused on cardiometabolic diseases, announced on Monday that it has appointed its cur.

NeuroBo Pharmaceuticals Enters Into Term Sheet With MThera Pharma to Out-license NB-01

NeuroBo Pharmaceuticals, Inc (NASDAQ:NRBO) Sees Large Decrease in Short Interest

NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO – Free Report) was the target of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 188,400 shares, a drop of 20.6% from the May 31st total of 237,400 shares. Based on an average daily trading volume, of 364,300 shares, […]

NeuroBo Pharmaceuticals, Inc (NASDAQ:NRBO) Short Interest Down 20 6% in June

NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO – Free Report) saw a large drop in short interest during the month of June. As of June 15th, there was short interest totalling 188,400 shares, a drop of 20.6% from the May 31st total of 237,400 shares. Based on an average daily trading volume, of 364,300 shares, the days-to-cover ratio […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.